Latest Breaking News On - China life private equity - Page 1 : vimarsana.com

GeneQuantum Raises Hundreds of Millions RMB in Series C Funding News provided by Share this article Share this article SUZHOU, China, May 18, 2021 /PRNewswire/ GeneQuantum Healthcare (Suzhou) Co., Ltd. (hereinafter GeneQuantum ) announced the completion of Series C fund raising of several hundreds of millions RMB. This series of fund raising is led by China Life Private Equity Investment, jointly by PICC Capital Equity Investment, Sunshine Guojian and Suzhou Wuzhong Biomedicine Industrial Park Investment. The current fund raising will provide a solid financial foundation to GeneQuantum for its global clinical development and pipeline expansion of next generation site-specific bioconjugates. Since its establishment, GeneQuantum has focused on the development of innovative bioconjugate drugs represented by Antibody-Drug-Conjugate (ADC). We possess highly differentiated ADC technology platforms, including enzyme catalyzed site-specific conjugation technology, innovative li

Guo jianGang qinLerming pharmaLeidi zhangInnovation fundHealthcare fundInvestment co ltdGenequantum healthcare suzhou co ltdRendong holdingSuzhou direct investment fundChina life health foundationCapital equity investment company limitedChina life healthcare fundSector fundTechnological development zoneWuzhong biomedicine industrial park investment co ltd